Aspirin Inc
Download as ppt, pdf0 likes701 views
Aspirin Inc. presents an opportunity to invest in a company developing an over-the-counter pill to provide fast relief from headaches, addressing a $2 billion market of 45 million chronic headache sufferers in the US. The management team has successful experience in pharmaceutical companies. With $5 million in funding, the company plans to protect its patented technology, launch sales and marketing in the US, expand internationally, and build inventory, with the goal of an IPO or acquisition within 4 years returning 20 times the initial investment.
Aspirin Inc
- 1. Aspirin Inc. The Cure For The Common Headache Investor Presentation
- 2. What if your head hurt so bad you couldnt see you couldnt drive you couldnt work You couldn't care for your children you couldnt function 45 million Americans suffer chronic headaches
- 3. What if a pill could make the pain go way in minutes? Relief is just seconds away 90% efficacy Proprietary Patented Technology What would 45 million people pay for instant relief?
- 4. Enormous Market 45M Americans x 2 headaches per month 1B Headaches per year $2B Per Year Market @ $2.00 per pill
- 5. Management Team CEO Mary Smith Founder/CEO BigProfitableCo acquired by EvenBiggerCo for a 12X ROI to Investors University of Maryland RH Smith MBA CFO Bob Andweve CFO Big Pharma R&D Division Harvard MBA VP Sales & Marketing Sally Cansell Grew Bandaid Inc Pharma Div Sales from $0 to $40M in 4 years Once sold ice to an Inuit COO Tom Cando 12 years as Manufacturing Head of Placebo Pills Inc Been There, Done That
- 6. Go To Market Scalable contract manufacturing agreement in place Sales Team with strong relationships with 5 of the top 8 drug stores In negotiations with Asian and European distributors Ready For Success
- 7. Competition Speed Fast Slow Aspirin Effectiveness High Low Hammer Coffee Tea
- 8. Financials (US Dollars In Millions) EBITA Earnings before Investments, Taxes and Amortization
- 9. Funding and Finance $5 Million Raise A Round No Additional Rounds Anticipated Use of Funds $1 Million for Intellectual Property Protection $2 Million for US Sales and Marketing $1 Million for International Distribution $1 Million for Inventory Anticipated IPO or Acquisition in 4 years Target $100+ Million or 20X Return